PT  - JOURNAL ARTICLE
AU  - Puja Mehta
AU  - Sebastian E.  Sattui
AU  - Kornelis S.M. van der Geest
AU  - Elisabeth Brouwer
AU  - Richard Conway
AU  - Michael S.  Putman
AU  - Philip C.  Robinson
AU  - Sarah L.  Mackie
TI  - Giant Cell Arteritis and COVID-19: Similarities and Discriminators. A Systematic Literature Review
AID  - 10.3899/jrheum.200766
DP  - 2020 Oct 15
TA  - The Journal of Rheumatology
PG  - jrheum.200766
4099  - http://www.jrheum.org/content/early/2021/01/12/jrheum.200766.short
4100  - http://www.jrheum.org/content/early/2021/01/12/jrheum.200766.full
AB  - Objective To identify shared and distinct features of giant cell arteritis (GCA) and coronavirus disease 2019 (COVID-19) to reduce diagnostic errors that could cause delays in correct treatment. Methods Two systematic literature reviews determined the frequency of clinical features of GCA and COVID-19 in published reports. Frequencies in each disease were summarized using medians and ranges. Results Headache was common in GCA but was also observed in COVID-19 (GCA 66%, COVID-19 10%). Jaw claudication or visual loss (43% and 26% in GCA, respectively) generally were not reported in COVID-19. Both diseases featured fatigue (GCA 38%, COVID-19 43%) and elevated inflammatory markers (C-reactive protein [CRP] elevated in 100% of GCA, 66% of COVID-19), but platelet count was elevated in 47% of GCA but only 4% of COVID-19 cases. Cough and fever were commonly reported in COVID-19 and less frequently in GCA (cough, 63% for COVID-19 vs 12% for GCA; fever, 83% for COVID-19 vs 27% for GCA). Gastrointestinal upset was occasionally reported in COVID-19 (8%), rarely in GCA (4%). Lymphopenia was more common in COVID-19 than GCA (53% in COVID-19, 2% in GCA). Alteration of smell and taste have been described in GCA but their frequency is unclear. Conclusion Overlapping features of GCA and COVID-19 include headache, fever, elevated CRP and cough. Jaw claudication, visual loss, platelet count and lymphocyte count may be more discriminatory. Physicians should be aware of the possibility of diagnostic confusion. We have designed a simple checklist to aid evidence-based evaluation of patients with suspected GCA.